Riskpilot← Back to searchSign inGet full accessChristina Jarnald AB
ABActiveOrg 5568310956Forsvägen 7Nursing and midwifery activities · NACE 8694Est. 20100 employees
Revenue 2025
—
EBITDA margin
—
+6% vs 2024
Equity ratio
98.3%
Financial strength
Net profit 2025
SEK 9K
-45% vs 2024
| Revenue | — | — |
| EBITDA | SEK -12K | +6% |
| Net profit | SEK 9K | -45% |
| Total assets | SEK 744K | -21% |
| Equity | SEK 732K | -21% |
| Employees | 0 | — |
Legal name
Christina Jarnald AB
Org number
5568310956
Legal form
Aktiebolag
NACE code
8694 · Nursing and midwifery activities
Founded
9 december 2010
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Föremålet för bolagets verksamhet är att bedriva friskvård, hälso- och sjukvård, informations- och utbildningsverksamhet inom frisk-, hälso- och sjukvården och därmed förenlig verksamhet.
Address
Forsvägen 7
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | — | — | — | — |
| Staff expenses | — | — | — | — | — |
| EBITDA | −4 | −8 | −15 | −12 | −12 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −4 | −8 | −15 | −12 | −12 |
| Net financials | 1 562 | 5 | 15 | 30 | 23 |
| Profit before tax | 1 557 | −3 | 0 | 18 | 11 |
| Tax | −0 | — | — | −2 | −2 |
| Net profit | 1 557 | −3 | 0 | 16 | 9 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 719 | 1 340 | 1 114 | 937 | 744 |
| Equity | 1 663 | 1 293 | 1 106 | 927 | 732 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 56 | 47 | 8 | 10 | 12 |
| Total debt | 56 | 47 | 8 | 10 | 12 |
EBITDA margin
-1166400.0%
This company
15.8%
Market median
-7382378% vs market
20212025
Equity ratio
98.3%
This company
38.2%
Market median
+157% vs market
20212025
Return on equity
1.2%
This company
18.4%
Market median
-93% vs market
20212025
Net profit margin
863300.0%
This company
8.1%
Market median
+10657925% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MC Chief Executive Officer | Chief Executive Officer | 2020 |
| Former (1) | ||
GE Audit | Audit | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Christina Jarnald AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gun Elisabeth Holm | Audit | 0 companies |
| Marion Christina Jarnald | Chief Executive Officer | 0 companies |
| Kim Kjell-Åke Jarnald | Deputy Board Member | 0 companies |